Rabeprazole sodium 5 mg

DRUG2 trials

Sponsors

Janssen Research & Development, LLC, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Gastroesophageal RefluxGastroesophageal Reflux Disease (GERD)

Phase 1

A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

CompletedNCT00747526

Janssen Research & Development, LLCGastroesophageal Reflux Disease (GERD)

Start: 2007-12-31End: 2012-02-29Updated: 2013-07-08

Phase 3

Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

CompletedNCT00992589

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Gastroesophageal Reflux

Start: 2009-11-30End: 2011-11-30Updated: 2013-05-22